Latest financial market updates and expert analysis
Analysis For the first time, Freshworks has closed a fiscal year—2025—with a GAAP profit, marking a significant corporate milestone. The central question now is whether the software provider can sustain this...
Shares of the telehealth provider Hims & Hers Health have experienced a dramatic rally following a major strategic reversal and...
Viking Therapeutics has progressed its obesity treatment program, centered on the drug candidate VK2735, into the pivotal Phase 3 stage...
The global pivot toward energy security is casting a powerful spotlight on NAC Kazatomprom, the world’s largest uranium producer. European...
The performance of Armour Residential REIT is currently navigating a market landscape dominated by expectations surrounding the U.S. Federal Reserve’s...
The narrative surrounding hydrogen technology firm Plug Power has long been dominated by significant losses and unmet targets. However, recent...
Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity....
Ultragenyx Pharmaceutical has reported significant progress in its clinical development for a rare genetic disorder. New data from a Phase...
The lidar technology firm Microvision is navigating a critical strategic shift. Having focused on research for years, the company is...
The biopharmaceutical firm Axsome Therapeutics is executing an aggressive growth strategy centered on commercial expansion and a rich development pipeline....
While The Trade Desk closed its last fiscal year with a solid increase in profit, the advertising technology specialist is...
